Table 2 Baseline outcomes and cannulation time in each groups
| Â | EPF | DGC | PPS | Total | Pvalue |
|---|---|---|---|---|---|
No. (%) | 71 (50.7) | 33 (23.6) | 36 (25.7) | 140 | Â |
Age, mean (SD) | 65.6 (14.3) | 61.1 (15.4) | 69.6 (12.8) | Â | 0.048 |
Sex (M/F) | 37/34 | 14/19 | 19/17 | Â | 0.608 |
PAD (Type I/II/III) | 11 (2/9/0) | 4 (0/4/0) | 11 (0/10/1) | Â | 0.146 |
Papillary contact, mean (SD) | 3.6 (2.99) | 5.4 (1.39) | 4.6 (0.76) | Â | 0.001 |
Unintentional pancreatic duct cannulation, | 16 | 33 | 36 | Â | Â |
Frequency, mean (SD) | 1.19 (0.4) | 3.36 (1.05) | 5.94 (0.33) | 40 (1.94) | <0.01 |
Pancreatic contrast injection | 2 | 1 | 2 | Â | 0.757 |
Procedure timex, sec (SD) | Â | Â | Â | Â | Â |
  Initial cannulation time | 262.3 (109.2) |  | 253.6 (35.5) | 259.4 (91.1) | 0.644 |
  Precut time | 339.8 (342.4) |  | 452.3 (469.1) | 377.7 (391.1) | 0.161 |
  Total cannulation time | 559.4 (412.8) | 314.8 (65.2) | 706.0 (469.4) | 559.7 (403.6) | < 0.05 |